Weight loss drugs like Wegovy and Zepbound are getting cheaper, if you are willing to pay out of pocket for the medications.

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such ...

Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections and, in ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

Discussion around international reference pricing (IRP) is intensifying as policymakers search for ways to address persistently high prescription drug costs in the United States. With news of the ...

President Trump has elevated an issue Democrats have been jawboning about for years. The president issued an executive order ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, has ...

In an executive order last week, President Donald Trump effectively instituted price controls on prescription drugs—not just ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...